TABLE 1.

Demographic and Clinical Characteristics of Subjects

HD
ParameterAll (n = 20)Early (n = 7)Control (n = 14)
Sex (n)
 M836
 F1248
Age (y)53.3 ± 12.1 (32.3–83.1)47.3 ± 11.6 (32.3–64.5)54.3 ± 12.9 (30.7–68.5)
Weight (kg)65.9 ± 11.1 (50.0–89.0)*71.7 ± 9.9 (60.0–89.0)75.7 ± 10.6 (58.0–95.0)
(CAG)n43.6 ± 2.8 (39–50)44.3 ± 3.9 (40–50)
Estimated disease duration (y)6.0 ± 5.5 (0.5–19.4)1.9 ± 1.5 (0.5–4.5)
UHDRS motor score35.2 ± 25.0 (8–80)15.0 ± 6.1 (8–27)
UHDRS TFC score6.4 ± 4.8 (0–13)11.9 ± 0.9 (11–13)
Shoulson–Fahn stage
 I77
 II30
 III40
 IV40
 V20
Handedness
 L203
 Ambidexter001
 R18710
  • * Significant difference between patients and controls (P < 0.05).

  • Values represent mean ± SD, with range in parentheses. UHDRS motor scale ranges from 0 to 124, with higher scores indicating more motor impairment. UHDRS TFC scale assesses ability to perform daily activities and ranges from 13 (no impairment) to 0 (total incapacity). TFC scores are further subdivided into 5 Shoulson–Fahn stages: I (representing TFC scores 11–13), II (scores 7–10), III (scores 3–6), IV (scores 1–2), and V (score 0).